Stockreport

Evofem Biosciences Completes Enrollment of Phase 3 Contraceptive Trial of Amphora Ahead of Schedule

Evofem Biosciences, Inc.  (EVFM) 
Last evofem biosciences, inc. earnings: 3/12 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: evofem.com